Medtronic, Inc. (MDT) PT Raised to $123 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $104.96 +6.15%
Rating Summary:
24 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
24 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
UBS analyst Matthew Taylor raised the price target on Medtronic, Inc. (NYSE: MDT) to $123.00 (from $120.00) while maintaining a Buy rating.
You May Also Be Interested In
- Medtronic to announce financial results for its second quarter of fiscal year 2027
- Nomad Foods Ltd (NOMD) PT Raised to $15 at Jefferies
- Zimmer Biomet (ZBH) PT Raised to $125 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
